{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:53:42Z","timestamp":1761533622397,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":4912,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1111\/j.1538-7836.2009.03367.x","type":"journal-article","created":{"date-parts":[[2009,7,13]],"date-time":"2009-07-13T07:24:21Z","timestamp":1247469861000},"page":"65-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"S1","title":["Genotype\/phenotype association in von Willebrand disease: is the glass half full or empty?"],"prefix":"10.1016","volume":"7","author":[{"given":"D.","family":"LILLICRAP","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0010","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/beha.2001.0139","article-title":"Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology","volume":"14","author":"Eikenboom","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0020","unstructured":"ISTH SSC VWF Database. 2008; http:\/\/www.vwf.group.shef.ac.uk\/. Accessed 23 January 2009."},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0025","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1538-7836.2007.02460.x","article-title":"A common 253-kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3","volume":"5","author":"Schneppenheim","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0030","doi-asserted-by":"crossref","first-page":"7937","DOI":"10.1073\/pnas.90.17.7937","article-title":"Mutations of von Willebrand factor gene in families with von Willebrand disease in the Aland Islands","volume":"90","author":"Zhang","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0035","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1079-9796(03)00033-0","article-title":"Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients","volume":"30","author":"Baronciani","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0040","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-2141.2000.02507.x","article-title":"Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease","volume":"111","author":"Lak","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0045","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1538-7836.2005.01219.x","article-title":"Theoretical structural explanation for Group I and Group II, type 2A von Willebrand disease mutations","volume":"3","author":"O\u2019Brien","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0050","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1126\/science.107355","article-title":"Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain","volume":"297","author":"Huizinga","year":"2002","journal-title":"Science"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0055","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: A cohort study of 67 patients","volume":"113","author":"Federici","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.V68.1.149.149","article-title":"A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers","volume":"68","author":"Weiss","year":"1986","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0065","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1172\/JCI116443","article-title":"von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure","volume":"91","author":"Holmberg","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0070","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1055\/s-0037-1616142","article-title":"Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen","volume":"86","author":"Ribba","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0075","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V112.11.424.424","article-title":"Characterisation of W1745C and S1783A, two novel collagen binding defects in the A3 domain of von Willebrand factor","volume":"112","author":"Riddell","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0080","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1538-7836.2008.02945.x","article-title":"Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)","volume":"6","author":"Budde","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0095","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1160\/TH06-07-0383","article-title":"An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease","volume":"96","author":"Cumming","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0092-8674(00)80964-2","article-title":"Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase","volume":"96","author":"Mohlke","year":"1999","journal-title":"Cell"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0105","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0110","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1182\/blood-2002-12-3693","article-title":"Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease","volume":"102","author":"O\u2019Brien","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0115","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood-2006-07-035105","article-title":"Effect of von Willebrand factor Y\/C1584 on in vivo protein level and function and interaction with ABO blood group","volume":"109","author":"Davies","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0120","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V99.1.180","article-title":"Reduced von Willebrand factor survival in type Vicenza von Willebrand disease","volume":"99","author":"Casonato","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0125","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03367.x_bb0130","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2009.03367.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622173873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622173873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2009.03367.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:51:29Z","timestamp":1761533489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622173873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":25,"alternative-id":["S1538783622173873"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03367.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genotype\/phenotype association in von Willebrand disease: is the glass half full or empty?","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03367.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}